Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers
Clinical trial NCT04485481 · COMPLETED
Trial details
- NCT number
- NCT04485481
- Sponsor
- Q32 Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2022-01-12
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.